KN

Kishan Narshibhai Bhalgama

Active Director Director DIN 10748197
DIN 10748197 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kishan Narshibhai Bhalgama

Data last updated:

Kishan Narshibhai Bhalgama is a Director at Cladviq Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10748197
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20242024Active

Board colleagues of Kishan Narshibhai Bhalgama

NameDINCompanyDesignation
Vidhi Kishan Bhalgama10008597Cladviq Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cladviq Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kishan Narshibhai Bhalgama

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kishan Narshibhai Bhalgama

Kishan Narshibhai Bhalgama currently holds 1 directorship: Cladviq Pharmaceuticals Private Limited (Director, since 20 Aug 2024).

Kishan Narshibhai Bhalgama was first appointed on 20 Aug 2024 as Director at Cladviq Pharmaceuticals Private Limited.

The current boards of Kishan Narshibhai Bhalgama's companies include Vidhi Kishan Bhalgama (Cladviq Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available